NEW YORK, Aug. 6 – MediChem Life Sciences’ subsidiary Emerald Biostructures said on Monday that it has hired three new scientists to direct the company’s protein crystallography and structure determination efforts.
Robin Clark, an expert on protein expression and purification, joins the company as director of protein research; Alex Burgin, a biochemist formerly at San Diego State University, arrives as director of biochemistry; and Sridhar Prasad, a crystallographer formerly at the Scripps Research Institute, comes on as director of crystallography.
The three scientists will help the company’s founders, Hidong Kim and Lance Stewart, to guide Emerald Biostructures’ technical development. They also will help provide leadership within the growing company, now with 35 employees, Lance Stewart, president of the Bainbridge, Wash.-based company, told GenomeWeb .
“What we’re doing is setting up teams of people who can handle the entire spectrum of [protein structure determination] research,” he said. “We also want to develop some key technologies and we chose these people to help us along the way.”
Clark most recently served as a consultant to Lawrence Livermore National Laboratory, and has studied the use of baculovirus expression systems to express and purify large types of proteins. He has also worked in various capacities for Cetus, Chiron, and Onyx Pharmaceuticals.
Burgin has studied enzyme structure and function, and most recently directed a research group at San Diego State University studying DNA recombinases and other important protein targets in cancer research.
Prasad has conducted research in protein crystallography at the University of Minnesota Medical School and, most recently, at the Scripps Research Institution.
Separately, MediChem hired Jasbir Singh, formerly director of medicinal chemistry at Cephalon, as vice president for medicinal chemistry.